Proshares Trust ZBIO
ZBIO
$28.18 +1.47 (+5.50%)
At close: Oct 20, 2026 · 4:00 PM EDT

Zenas BioPharma (ZBIO) EPS (Basic) (2023 - 2026)

Updated

Zenas BioPharma (ZBIO) recorded EPS (Basic) of -$1.77 in Q2 2026, compared with -$1.25 a year earlier.

Analysis

Zenas BioPharma (ZBIO) EPS (Basic) (2023 - 2026) Analysis & Trends

On a TTM basis, Zenas BioPharma's EPS (Basic) came in at -$7.67 as of Jun 30, 2026; for FY2025, it was -$8.44.

  • Across earlier years, EPS (Basic) came in at -$11.89 in FY2024 and -$24.25 in FY2023.
  • Quarterly EPS (Basic) has ranged from -$24.23 in Q2 2024 to $23.15 in Q3 2023 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$1.46 (Q1 2026), -$5.38 (Q4 2025) and -$1.22 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 7.95
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 2.30
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 2.04
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -0.54
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.68
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 1.62
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 4.40
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -8.44
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -0.04
10 Zenas BioPharma 1.77 Bn 1.10 Bn - -1.77
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.77
Mar 31, 2026 -1.46
Dec 31, 2025 -5.38
Sep 30, 2025 -1.22
Jun 30, 2025 -1.25
Mar 31, 2025 -0.80
Dec 31, 2024 -3.99
Sep 30, 2024 -5.02
Jun 30, 2024 -24.23
Mar 31, 2024 -17.89
Dec 31, 2023 -16.06
Sep 30, 2023 23.15
API Access

Zenas BioPharma EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=ZBIO&period=max&api_key=YOUR_API_KEY